PureTech Scientific (Iron Path Capital) Acquires Glycolic Acid Business from The Chemours Company for $137 Million
June 1, 2023
PureTech Scientific, a company founded and backed by Iron Path Capital, agreed to acquire The Chemours Company's Glycolic Acid business for $137 million in cash. The transaction (a carve-out/divestiture) closed in August 2023 and creates a standalone platform focused on high‑purity alpha hydroxy acids for life sciences, specialty chemicals and personal care end markets.
- Targets
- Glycolic Acid business (The Chemours Company)
- Sellers
- The Chemours Company
- Industry
- Manufacturing
- Location
- West Virginia, United States
- Transaction Type
- Divestiture
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.